Skip to main content

Biotech And Healthcare Stocks Poised For Gains Ahead

The XLV bounced off the bottom this month up 4% to the $144 level led by biopharma and medtech.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.